Scleroderma Recruiting Phase 2 / 3 Trials for Cyclophosphamide (DB00531)

Also known as: Dermatosclerosis

IndicationStatusPhase
DBCOND0013449 (Scleroderma)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01862926Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILDTreatment